United Therapeutics (UTHR) EPS (Diluted) (2009 - 2026)
United Therapeutics' EPS (Diluted) came in at $7.27 for Q2 2026, up 13.5% from $6.41 a year earlier and up 24.8% from the prior quarter.
Powered by 
Analysis
United Therapeutics (UTHR) EPS (Diluted) (2009 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, United Therapeutics reported EPS (Diluted) of $28.62, up 11.3% year-over-year; for FY2025, it was $27.86, up 13.1% from FY2024.
- EPS (Diluted) has increased in each of the last four years, with a five-year compound annual growth rate of 19.3% (FY2020 to FY2025).
- Going back by year, EPS (Diluted) was $24.64 in FY2024 (+24.4%), $19.81 in FY2023 (+32.1%), $15.00 in FY2022 (+49.1%) and $10.06 in FY2021 (-12.9%).
- The five-year range for quarterly EPS (Diluted) is $2.37 (Q4 2021) to $7.61 (Q4 2025).
- Year-over-year, EPS (Diluted) increased in seven of the last eight quarters, with growth averaging 14.2%.
- The fastest year-over-year change in EPS (Diluted) over five years came in Q1 2022 (growth of 724.6%), and the weakest in Q2 2022 (a decline of 33.9%).
- Business Quant data shows UTHR's EPS (Diluted) at $5.82 (Q1 2026), $7.61 (Q4 2025) and $7.16 (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 2.27 |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.04 |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | -0.54 |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 1.67 |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 1.85 |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 4.37 |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | -8.44 |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | -0.04 |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 4.31 |
| 10 | United Therapeutics | 20.72 Bn | 10.22 Bn | 683.80 Mn | 7.27 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.27 |
| Mar 31, 2026 | 5.82 |
| Dec 31, 2025 | 7.61 |
| Sep 30, 2025 | 7.16 |
| Jun 30, 2025 | 6.41 |
| Mar 31, 2025 | 6.63 |
| Dec 31, 2024 | 6.21 |
| Sep 30, 2024 | 6.39 |
| Jun 30, 2024 | 5.85 |
| Mar 31, 2024 | 6.17 |
| Dec 31, 2023 | 4.37 |
| Sep 30, 2023 | 5.38 |
| Jun 30, 2023 | 5.24 |
| Mar 31, 2023 | 4.86 |
| Dec 31, 2022 | 2.72 |
| Sep 30, 2022 | 4.91 |
| Jun 30, 2022 | 2.41 |
| Mar 31, 2022 | 5.03 |
| Dec 31, 2021 | 2.37 |
| Sep 30, 2021 | 3.42 |
API Access
United Therapeutics EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=UTHR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "UTHR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=UTHR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();